Pang, H., Yan, K., Kratzke, R., Stinchcombe, T., Crawford, J., Kindler, H., … Wang, X. (2017). P3.03-036 Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance). In Journal of Thoracic Oncology (Vol. 12, pp. S1367–S1367). Elsevier BV. https://doi.org/10.1016/j.jtho.2016.11.1935

Pang, Herbert, Kang Yan, Robert Kratzke, Thomas Stinchcombe, Jeffrey Crawford, Hedy Kindler, Everett Vokes, and Xiaofei Wang. “P3.03-036 Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance).” In Journal of Thoracic Oncology, 12:S1367–S1367. Elsevier BV, 2017. https://doi.org/10.1016/j.jtho.2016.11.1935.

Pang H, Yan K, Kratzke R, Stinchcombe T, Crawford J, Kindler H, et al. P3.03-036 Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance). In: Journal of Thoracic Oncology. Elsevier BV; 2017. p. S1367–S1367.

Pang, Herbert, et al. “P3.03-036 Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance).” Journal of Thoracic Oncology, vol. 12, no. 1, Elsevier BV, 2017, pp. S1367–S1367. Crossref, doi:10.1016/j.jtho.2016.11.1935.

Pang H, Yan K, Kratzke R, Stinchcombe T, Crawford J, Kindler H, Vokes E, Wang X. P3.03-036 Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance). Journal of Thoracic Oncology. Elsevier BV; 2017. p. S1367–S1367.